Creative Medical Technology Stock Performance
| CELZ Stock | USD 2.17 0.14 6.06% |
The firm shows a Beta (market volatility) of 1.01, which signifies a somewhat significant risk relative to the market. Creative Medical returns are very sensitive to returns on the market. As the market goes up or down, Creative Medical is expected to follow. At this point, Creative Medical Tec has a negative expected return of -0.36%. Please make sure to confirm Creative Medical's market risk adjusted performance, jensen alpha, as well as the relationship between the Jensen Alpha and daily balance of power , to decide if Creative Medical Tec performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Creative Medical Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (3.35) | Five Day Return 1.32 | Year To Date Return (49.78) | Ten Year Return (99.97) | All Time Return (99.97) |
Last Split Factor 1:10 | Dividend Date 2020-02-03 | Last Split Date 2023-06-12 |
1 | Disposition of 10000000 shares by Ichim Thomas of Creative Medical at 0.004 subject to Rule 16b-3 | 09/26/2024 |
2 | Are Pharma Stocks Harmful To Your Financial Health | 10/10/2024 |
3 | Creative Medical Technology Completes 1.6 Million Registered Direct Offering PHOENIX, October 23, 2024 Creative Medical Technology Holdings, Inc. finalized a se... | 10/24/2024 |
4 | Creative Medical Technology files to sell 0.83M shares of common stocks by selling shareholders - MSN | 11/15/2024 |
5 | CELZ stock touches 52-week low at 2.36 amid market challenges - Investing.com | 12/03/2024 |
6 | CELZ stock touches 52-week low at 2.21 amid market challenges - Investing.com | 12/11/2024 |
| Begin Period Cash Flow | 8.3 M |
Creative |
Creative Medical Relative Risk vs. Return Landscape
If you would invest 339.00 in Creative Medical Technology on September 14, 2024 and sell it today you would lose (108.00) from holding Creative Medical Technology or give up 31.86% of portfolio value over 90 days. Creative Medical Technology is currently does not generate positive expected returns and assumes 7.0609% risk (volatility on return distribution) over the 90 days horizon. In different words, 62% of stocks are less volatile than Creative, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Creative Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Creative Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Creative Medical Technology, and traders can use it to determine the average amount a Creative Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0511
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CELZ |
Estimated Market Risk
| 7.06 actual daily | 62 62% of assets are less volatile |
Expected Return
| -0.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Creative Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Creative Medical by adding Creative Medical to a well-diversified portfolio.
Creative Medical Fundamentals Growth
Creative Stock prices reflect investors' perceptions of the future prospects and financial health of Creative Medical, and Creative Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Creative Stock performance.
| Return On Equity | -0.57 | ||||
| Return On Asset | -0.36 | ||||
| Operating Margin | (511.82) % | ||||
| Current Valuation | (2.01 M) | ||||
| Shares Outstanding | 1.75 M | ||||
| Price To Earning | (54.81) X | ||||
| Price To Book | 0.65 X | ||||
| Price To Sales | 386.11 X | ||||
| Revenue | 9 K | ||||
| Gross Profit | 39.8 K | ||||
| EBITDA | (5.53 M) | ||||
| Net Income | (5.29 M) | ||||
| Cash And Equivalents | 22.86 M | ||||
| Cash Per Share | 1.62 X | ||||
| Total Debt | 14.19 K | ||||
| Current Ratio | 58.88 X | ||||
| Book Value Per Share | 4.93 X | ||||
| Cash Flow From Operations | (8.03 M) | ||||
| Earnings Per Share | (3.80) X | ||||
| Market Capitalization | 4.25 M | ||||
| Total Asset | 10.72 M | ||||
| Retained Earnings | (59.1 M) | ||||
| Working Capital | 9.9 M | ||||
About Creative Medical Performance
Evaluating Creative Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Creative Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Creative Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 668.56 | 701.99 | |
| Return On Tangible Assets | (0.51) | (0.54) | |
| Return On Capital Employed | (0.54) | (0.57) | |
| Return On Assets | (0.49) | (0.52) | |
| Return On Equity | (0.51) | (0.54) |
Things to note about Creative Medical Tec performance evaluation
Checking the ongoing alerts about Creative Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Creative Medical Tec help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Creative Medical Tec generated a negative expected return over the last 90 days | |
| Creative Medical Tec has high historical volatility and very poor performance | |
| Creative Medical Tec has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 9 K. Net Loss for the year was (5.29 M) with profit before overhead, payroll, taxes, and interest of 39.8 K. | |
| Creative Medical Technology currently holds about 22.86 M in cash with (8.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62. | |
| Creative Medical Tec has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: CELZ stock touches 52-week low at 2.21 amid market challenges - Investing.com |
- Analyzing Creative Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Creative Medical's stock is overvalued or undervalued compared to its peers.
- Examining Creative Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Creative Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Creative Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Creative Medical's stock. These opinions can provide insight into Creative Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.